RU2017108985A3 - - Google Patents

Download PDF

Info

Publication number
RU2017108985A3
RU2017108985A3 RU2017108985A RU2017108985A RU2017108985A3 RU 2017108985 A3 RU2017108985 A3 RU 2017108985A3 RU 2017108985 A RU2017108985 A RU 2017108985A RU 2017108985 A RU2017108985 A RU 2017108985A RU 2017108985 A3 RU2017108985 A3 RU 2017108985A3
Authority
RU
Russia
Application number
RU2017108985A
Other versions
RU2788450C2 (ru
RU2017108985A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2017108985A publication Critical patent/RU2017108985A/ru
Publication of RU2017108985A3 publication Critical patent/RU2017108985A3/ru
Application granted granted Critical
Publication of RU2788450C2 publication Critical patent/RU2788450C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2017108985A 2010-01-11 2011-01-10 Способы проведения терапии потери веса у пациентов с доминирующей депрессией RU2788450C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29384410P 2010-01-11 2010-01-11
US61/293,844 2010-01-11

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2012128109A Division RU2616496C2 (ru) 2010-01-11 2011-01-10 Способы проведения терапии потери веса у пациентов с доминирующей депрессией (варианты)

Publications (3)

Publication Number Publication Date
RU2017108985A RU2017108985A (ru) 2019-01-22
RU2017108985A3 true RU2017108985A3 (ru) 2020-06-26
RU2788450C2 RU2788450C2 (ru) 2023-01-19

Family

ID=

Also Published As

Publication number Publication date
AU2011203867A1 (en) 2012-07-19
AU2016201325A1 (en) 2016-03-17
EP2523557B1 (en) 2019-09-25
RU2012128109A (ru) 2014-02-20
KR101841442B1 (ko) 2018-03-23
US20110172260A1 (en) 2011-07-14
US11033543B2 (en) 2021-06-15
EP2523557A1 (en) 2012-11-21
KR20170121333A (ko) 2017-11-01
JP2016138142A (ja) 2016-08-04
IL248319A0 (en) 2016-11-30
BR112012016783A2 (pt) 2015-09-01
WO2011085331A1 (en) 2011-07-14
KR20120124423A (ko) 2012-11-13
US20210299119A1 (en) 2021-09-30
EP2523557A4 (en) 2014-04-30
AU2016201325B2 (en) 2017-12-21
US9248123B2 (en) 2016-02-02
EP3659604A1 (en) 2020-06-03
MX344303B (es) 2016-12-13
AU2011203867B2 (en) 2015-12-03
IL220610A0 (en) 2012-08-30
ES2762113T3 (es) 2020-05-22
US10322121B2 (en) 2019-06-18
CN102724878A (zh) 2012-10-10
JP6196041B2 (ja) 2017-09-13
US20190290640A1 (en) 2019-09-26
IL220610A (en) 2016-10-31
JP2013516493A (ja) 2013-05-13
US20160143903A1 (en) 2016-05-26
RU2616496C2 (ru) 2017-04-17
CA2785822C (en) 2019-06-25
MX2012007898A (es) 2012-08-01
CA2785822A1 (en) 2011-07-14
RU2017108985A (ru) 2019-01-22
IL248319B (en) 2020-06-30

Similar Documents

Publication Publication Date Title
BR112013008959A2 (ru)
BR112012031500A2 (ru)
BR112012029986A2 (ru)
BR112012030039A2 (ru)
BR112012028408A2 (ru)
BR112012026492A2 (ru)
BR112012027808A2 (ru)
BR112012024897A2 (ru)
BR112012025307A2 (ru)
BR112012026946A2 (ru)
BR112012025482A2 (ru)
BR112013006400A2 (ru)
BR112012028186A2 (ru)
BR112012031826A2 (ru)
BR112012025577A2 (ru)
BR112012027015A2 (ru)
BR112012025308A2 (ru)
BR112012027945A2 (ru)
BR112012024872A2 (ru)
BR112013010949A2 (ru)
BR112013003284A2 (ru)
BR112013002646A2 (ru)
BR112012026403A2 (ru)
BR112013006825A2 (ru)
BR112012028859A2 (ru)